Filament Health Corp
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provide… Read more
Filament Health Corp (FLHLF) - Total Assets
Latest total assets as of December 2024: $3.41 Million USD
Based on the latest financial reports, Filament Health Corp (FLHLF) holds total assets worth $3.41 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Filament Health Corp - Total Assets Trend (2020–2024)
This chart illustrates how Filament Health Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Filament Health Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Filament Health Corp's total assets of $3.41 Million consist of 20.2% current assets and 79.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.5% |
| Accounts Receivable | $182.54K | 5.4% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $460.00K | 13.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Filament Health Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Filament Health Corp's current assets represent 20.2% of total assets in 2024, a decrease from 100.0% in 2020.
- Cash Position: Cash and equivalents constituted 11.5% of total assets in 2024, down from 99.6% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 13.5% of total assets.
Filament Health Corp Competitors by Total Assets
Key competitors of Filament Health Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Filament Health Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Filament Health Corp generates 0.18x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Filament Health Corp is currently not profitable relative to its asset base.
Filament Health Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.44 | 1.72 | 19.33 |
| Quick Ratio | 0.44 | 1.72 | 19.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-859.51K | $ 1.15 Million | $ 7.96 Million |
Filament Health Corp - Advanced Valuation Insights
This section examines the relationship between Filament Health Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.00 |
| Latest Market Cap to Assets Ratio | 0.53 |
| Asset Growth Rate (YoY) | -38.8% |
| Total Assets | $3.41 Million |
| Market Capitalization | $1.80 Million USD |
Valuation Analysis
Below Book Valuation: The market values Filament Health Corp's assets below their book value (0.53 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Filament Health Corp's assets decreased by 38.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Filament Health Corp (2020–2024)
The table below shows the annual total assets of Filament Health Corp from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $3.41 Million | -38.81% |
| 2023-12-31 | $5.58 Million | +17.62% |
| 2022-12-31 | $4.74 Million | -73.43% |
| 2021-12-31 | $17.84 Million | +1923.92% |
| 2020-12-31 | $881.56K | -- |